Skip to main content Help with accessibility Skip to main navigation

Liothyronine

Indication

Add-on treatment for refractory hypothyroidism in secondary care – new patients.

Grey

Brand:

Nice TA:

Commissioning responsibility:

CCG

PbR excluded:

No

BNF chapter:
Endocrine system

Background

Liothyronine is not recommended for use in secondary care for new patients where disease stabilisation is unachievable with levothyroxine alone.

Recommendation

LSCMMG Recommendation:

Grey

Reason for decision:

Prioritised for review

Supporting documents:

Decisions of Lancashire local decision making groups

Pending
Pending
Pending
Pending
Pending
Pending
Pending
Pending
What do the colours mean?

Last Updated: 20 - May - 2021